retatrutide phase 2 obesity nejm 2023 jastreboff Another Promising Medication (Retatrutide) for Retatrutide Weight Loss Results |

The Data: In recent Phase 3 trials, patients on the highest dose lost an average of 28.7% of their body weight

10.1194/jlr.RA120000737 14 Cakir-AktasC.BodurE.YemisciM.van LeyenK.KaratasH

Emerging evidence suggests that GPER may indirectly modulate vitamin D metabolism by altering intracellular calcium levels and influencing VDR activity [106, 107]

Its something to be aware of and something that, you know, we have to look within ourselves and theres so many different tools and, you know, resources available that it doesnt have to stay like that

The daily recommendation for most adults is Vitamin B-6 is available as a standalone supplement